XAIR
Beyond Air, Inc.
There isn't enough reported data to score XAIR yet.
XAIR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Unavailable | |
| Unavailable |
XAIR's revenue is currently healthy, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
XAIR PE Valuation
XAIR has no meaningful PE right now: it lost money over the past year.
XAIR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect XAIR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
XAIR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | -$424.00 | +$429.13 |
| Q3 2024 | -$564.00 | +$261.13 |
| Q2 2024 | -$656.00 | +$125.13 |
| Q1 2024 | -$728.00 | +$21.13 |
| Q4 2023 | -$853.13 | -$74.83 |
| Q3 2023 | -$825.13 | -$102.83 |
| Q2 2023 | -$781.13 | -$74.83 |
| Q1 2023 | -$749.13 | -$66.83 |
XAIR is still losing money, but far less than before: $424.00 per share over the past year, against $853.13 at its worst in late 2023.
XAIR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $1.2M | +145% |
| Q4 2024 | $1.1M | +174% |
| Q3 2024 | $798K | +234% |
| Q2 2024 | $683K | +1058% |
| Q4 2020 | $148.8K | -53% |
XAIR's revenue has grown year over year for six quarters in a row: $1M last quarter, up 145% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2025 | -623% | +2065 points |
| Q4 2024 | -1022% | +3317 points |
| Q3 2024 | -1608% | +5729 points |
| Q2 2024 | -1988% | +24919 points |
| Q1 2024 | -2688% | N/A |
| Q4 2023 | -4338% | N/A |
| Q3 2023 | -7337% | N/A |
| Q2 2023 | -26907% | N/A |
XAIR's operating margin was −623% last quarter, up 2065 points from the same quarter a year ago, near the top of its range since 2019.
XAIR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.3M | -$1.6M |
| Q2 2026 | -$5.2M | -$430K |
| Q1 2026 | -$5.5M | +$3M |
| Q4 2025 | -$4.3M | +$4M |
| Q3 2025 | -$4.7M | +$9.8M |
| Q2 2025 | -$4.7M | +$8.1M |
| Q1 2025 | -$8.5M | +$4.2M |
| Q4 2024 | -$8.3M | +$6.9M |
XAIR has burned cash in almost every quarter: −$21M over the past year, against −$26M the year before.
XAIR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +188% | +1.4M shares |
| 1 year | +729% | +1.8M shares |
| 3 years | +2679% | +2M shares |
| 5 years | +4757% | +2M shares |
XAIR has 2M diluted shares, up 729% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
XAIR Net Leverage
XAIR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XAIR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.2 | Oversold |
| Stochastic | 4.0 | Oversold |
XAIR's weekly RSI is 27 (oversold) and its Stochastic is 4 (oversold).
XAIR PE vs Healthcare Sector
XAIR has no meaningful PE right now: it lost money over the past year.
XAIR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.35 | 6% below |
| 20 week MA | $4.18 | 47% below |
| 50 week MA | $11.3 | 80% below |
| 100 week MA | $48.1 | 95% below |
| 200 week MA | $542.0 | 100% below |
XAIR is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
XAIR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,752.0 | $2,084.0 | +19% |
| 2021 | $2,084.0 | $3,916.0 | +88% |
| 2022 | $3,916.0 | $2,496.0 | -36% |
| 2023 | $2,496.0 | $784.0 | -69% |
| 2024 | $784.0 | $176.0 | -78% |
| 2025 | $176.0 | $15.0 | -91% |
| 2026 YTD | $15.0 | $2.21 | -85% |
XAIR has finished four years in a row lower, and it's down 85% so far in 2026.